Nuclear envelope and striated muscle diseases

Current Opinion in Cell Biology

Volumn 32, Issue , 2015, Pages 1-6

  Chatzifrangkeskou, Maria ^a,b,c,d   Bonne, Gisèle ^a,b,c,d,e   Muchir, Antoine ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b Sorbonne Université   (France)

^c CNRS   (France)

^d Institut de Myologie   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIN;

CELL NUCLEUS MEMBRANE; GENE; GENE EXPRESSION; GENE MUTATION; LAMINOPATHY; MUSCLE DISEASE; NONHUMAN; NUCLEAR LAMINA; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; STRIATED MUSCLE DISEASE; ANIMAL; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; SKELETAL MUSCLE;

ANIMALS; HUMANS; LAMINS; MUSCLE, STRIATED; MUSCULAR DISEASES; MUTATION; NUCLEAR ENVELOPE; NUCLEAR LAMINA;

EID: 84908283695     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2014.09.007     Document Type: Review

References (58)

1. Fawcett W.D. On the occurrence of a fibrous lamina on the inner aspect of the nuclear envelope in certain cells of vertebrates. Am J Anat 1999, 119:129-145.
2. Aaronson R.P., Blobel G. Isolation of nuclear pore complexes in association with a lamina. Proc Natl Acad Sci U S A 1975, 72:1007-1011.
3. Dwyer N., Blobel G. A modified procedure for the isolation of a pore complex-lamina fraction from rat liver nuclei. J Cell Biol 1976, 70:581-591.
4. Gerace L., Blum A., Blobel G. Immunocytochemical localization of the major polypeptides of the nuclear pore complex-lamina fraction. Interphase and mitotic distribution. J Cell Biol 1978, 79:546-566.
5. Fisher D.Z., Chaudhary N., Blobel G. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci U S A 1986, 83:6450-6454.
6. McKeon F.D., Kirschnen M.W., Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 1986, 319:463-468.
7. Lin F., Worman H.J. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Cell Biol 1993, 268:16321-16326.
8. Guilly M.N., Bensussan A., Bourge J.F., Bornens M., Courvalin J.C. A human T lymphoblastic cell line lacks lamins A and C. EMBO J 1987, 6:3795-3799.
9. Guilly M.N., Kolb J.P., Gosti F., Godeau F., Courvalin J.C. Lamins A and C are not expressed at early stages of human lymphocyte differentiation. Exp Cell Res 1990, 189:145-147.
10. Lebel S., Lampron C., Royal A., Raymond Y. Lamins A and C appear during retinoic acid-induced differentiation of mouse embryonal carcinoma cells. J Cell Biol 1987, 105:1099-1104.
11. Stewart C., Burke B. Teratocarcinoma stem cells and early mouse embryos contain only a single major lamin polypeptide closely resembling lamin B. Cell 1987, 51:383-392.
12. Worman H.J., Lazaridis I., Georgatos S.D. Nuclear lamina heterogeneity in mammalian cells. Differential expression of the major lamins and variations in lamin B phosphorylation. J Cell Biol 1988, 263:12135-12141.
13. Rober R.A., Weber K., Osborn M. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 1989, 105:365-378.
14. Rober R.A., Sauter H., Weber K., Osborn M. Cells of the cellular immune and hemopoietic system of the mouse lack lamins A/C: distinction versus other somatic cells. J Cell Sci 1990, 95:587-598.
15. Cance W.G., Chaudhary N., Worman H.J., Blobel G., Cordoncardo C. Expression of the nuclear lamins in normal and neoplastic human tissues. J Exp Clin Can Res 1992, 11:233-246.
16. Bonne G., Di Barletta M.R., Varnous S., Bécane H.M., Hammouda E.H., Merlini L., Muntoni F., Greenberg C.R., Gary F., Urtizberea J.A., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Gen 1999, 21:285-288.
17. Muchir A., Worman H.J. Emery-Dreifuss muscular dystrophy. Curr Neurol Neurosci Rep 2007, 7:78-83.
18. Meune C., Van Berlo J.H., Anselme F., Bonne G., Pinto Y.M., Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006, 354:209-210.
19. Ben Yaou R., Muchir A., Arimura T., Massart C., Demay L., Richard P., Bonne G. Genetics of laminopathies. Nuclear Organization in Development and Disease 2008, vol 264. Novartis Foundation Symposium. 10.1002/0470093765.ch7.
20. Fatkin D., MacRae C., Sasaki T., Walff M.R., Porcu M., Frenneaux M., Atherton J., Vidaillet H., Spudich S., De Girolami U. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999, 341:1715-1724.
21. Muchir A., Bonne G., van der Kooi A.J., van Meegen M., Baas F., Bolhuis P., de Visser M., Schwartz K. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 2000, 9:1453-1459.
22. Quijano-Roy S., Mbieleu B., Bönnemann C.G., Jeannet P.Y., Colomer J., Clarke N.F., Cuisset J.M., Roper H., De Meirleir L., D'Amico A., et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol 2008, 64:177-186.
23. Granger B., Gueneau L., Drouin-Garraud V., Pedergnana V., Gagnon F., Ben Yaou R., Tezenas du Montcel S., Bonne G. Modifier locus of the skeletal muscle involvement in Emery-Dreifuss muscular dystrophy. Hum Gen 2011, 129:149-159.
24. Cao K. Cellular basis of laminopathies. eLS 2012, 10.1002/9780470015902.a0022533.
25. Favreau C., Higuet D., Courvalin J.C., Buendia B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol 2004, 24:1481-1492.
26. Johnson B.R., Nitta R.T., Frock R.L., Mounkes L., Barbie D.A., Stewart C.L., Harlow E., Kennedy B.K. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci U S A 2004, 101:9677-9682.
27. Nitta R., Jameson S., Kudlow B., Conlan L.A., Kennedy B. Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest. Mol Cell Biol 2006, 26:5360-5372.
28. Frock R.L., Kudlow B.A., Evans A.M., Jameson S.A., Hauschka S.D., Kennedy B.K. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev 2006, 204:486-500.
29. Östlund C., Bonne G., Schwartz K., Worman H.J. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J Cell Sci 2001, 114:4435-4445.
30. Ognibene A., Sabatelli P., Petrini S., Squarzoni S., Riccio M., Santi S., Villanova M., Palmeri S., Merlini L., Maraldi N.M. Nuclear changes in a case of X-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve 1999, 22:864-869.
31. Fidziańska A., Hausmanowa-Petrusewicz I. Architectural abnormalities in muscle nuclei. Ultrastructural differences between X-linked and autosomal dominant forms of EDMD. J Neurol Sci 2003, 210:47-51.
32. Sylvius N., Bilinska Z.T., Veinot J.P., Fidzianska A., Bolongo P.M., Poon S., McKeown P., Davies R.A., Chan K.L., Tang A.S.L. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 2005, 42:639-647.
33. Stewart C.L., Roux K.J., Burke B. Blurring the boundary: the nuclear envelope extends its reach. Science 2007, 318:1408-1412.
34. Lombardi M.L., Lammerding J. Keeping the LINC: the importance of nucleocytoskeletal coupling in intracellular force transmission and cellular function. Biochem Soc Trans 2011, 39:1729-1734.
35. -/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum Mol Genet 2004, 13:2567-2580.
36. Lammerding J.P., Schulze C., Takahashi T., Kozlov S., Sullivan T., Kamm R.D., Stewart C.L., Lee R.T. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004, 113:370-378.
37. Lammerding J., Lee R.T. The nuclear membrane and mechanotransduction: impaired nuclear mechanics and mechanotransduction in lamin A/C-deficient cells. Novartis Found Symp 2006, 264:264.
38. Bertrand A.T., Ziaei S., Ehret C., Duchemin H., Mamchaoui K., Bigot A., Mayer M., Quijano-Roy S., Desguerre I., Laine J., et al. Cellular microenvironments reveal defective mechanosensing response and elevated YAP signaling in LMNA-mutated muscle precursors. J Cell Sci 2014, 127(Pt 13):2873-2884.
39. Glass C.A., Glass J.R., Taniura H., Hasel K.W., Blevitt J.M., Gerace L. The alpha-helical rod domain of human lamins A and C contains a chromatin binding site. EMBO J 1993, 12:4413.
40. Dreuillet C., Tillit J., Kress M., Ernoult-Lange M. In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C. Nucl Acids Res 2002, 30:4634-4642.
41. Mancini M.A., Shan B., Nickerson J.A., Penman S., Lee W.H. The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc Natl Acad Sci 1994, 91:418-422.
42. Lloyd D.J., Trembath R.C., Shackleton S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002, 11:769-777.
43. Muchir A., Pavlidis P., Decostre V., Herron A.J., Arimura T., Bonne G., Worman H.J. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest 2007, 117:1282-1293.
44. Bank E.M., Gruenbaum Y. Caenorhabditis elegans as a model system for studying the nuclear lamina and laminopathic diseases. Nucleus 2011, 2:350-357.
45. Dialynas G., Flannery K.M., Zirbel L.N., Nagy P.L., Mathews K.D., Moore S.A., Wallrath L.L. LMNA variants cause cytoplasmic distribution of nuclear pore proteins in Drosophila and human muscle. Hum Mol Genet 2012, 21:1544-1556.
46. Dialynas G., Speese S., Budnik V., Geyer P.K., Wallrath L.L. The role of Drosophila Lamin C in muscle function and gene expression. Development 2010, 137:3067-3077.
47. Zwerger M., Jaalouk D.E., Lombardi M.L., Isermann P., Mauermann M., Dialynas G., Herrmann H., Wallrath L.L., Lammerding J. Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. Hum Mol Genet 2013, 22:2335-2349.
48. Sullivan T., Escalante-Alcalde D., Bhatt H., Anver M., Bhat N., Nagashima K., Stewart C.L., Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999, 147:913-920.
49. -/- mouse line: implications for the understanding of laminopathies. Nucleus 2012, 3:463-475.
50. Arimura T., Helbling-Leclerc A., Massart C., Varnous S., Niel F., Lacène E., Fromes Y., Toussaint M., Mura A.M., et al. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 2005, 14:155-169.
51. Bertrand A.T., Renou L., Papadopoulos A., Beuvin M., Lacène E., Massart C., Ottolenghi C., Decostre V., Maron S., Schlossarek S., et al. DelK32-lamin A/C has abnormal location and induces incomplete tissue maturation and severe metabolic defects leading to premature death. Hum Mol Genet 2012, 21:1037-1048.
52. Mounkes L.C., Kozlov S.V., Rottman J.N., Stewart C.L. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet 2005, 14:2167-2180.
53. delK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity. Hum Mol Genet 2013, 22:3152-3164.
54. Wang Y., Herron A.J., Worman H.J. Pathology and nuclear abnormalities in hearts of transgenic mice expressiong M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Hum Mol Genet 2006, 15:2479-2489.
55. Dauer W.T., Worman H.J. The nuclear envelope as a signaling node in development and disease. Dev Cell 2009, 17:626-638.
56. Muchir A., Wu W., Worman H.J. Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. BBA-Mol Basis Dis 2009, 1792:75-81.
57. Muchir A., Reilly S.A., Wu W., Iwata S., Homma S., Bonne G., Worman H.J. Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene. Cardiovasc Res 2012, 93:311-319.
58. Choi J.C., Muchir A., Wu W., Iwata S., Homma S., Morrow J.P., Worman H.J. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. J Biol Chem 2012, 4:144ra102.